Comparative Cost-effectiveness Analysis of Theophylline and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
- 1 March 1993
- journal article
- research article
- Published by Elsevier BV in Chest
- Vol. 103 (3), 678-684
- https://doi.org/10.1378/chest.103.3.678
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletineThe American Journal of Cardiology, 1991
- A Clinician's Guide to Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1990
- How to Evaluate DrugsPublished by American Medical Association (AMA) ,1990
- Costs of medical and surgical treatment of duodenal ulcerGastroenterology, 1989
- Lithium and the Single Episode When to Begin Long-term Prophylaxis for Bipolar DisorderMedical Care, 1987
- A computer-based markov decision analysis of the management of symptomatic bifascicular block: The threshold probability for pacingJournal of the American College of Cardiology, 1987
- Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomAmerican Journal Of Medicine, 1987
- A Cost-effectiveness Analysis of Cyclosporine in Cadaveric Kidney TransplantationMedical Decision Making, 1986
- The Markov Process in Medical PrognosisMedical Decision Making, 1983
- The Addition of An Aerosol Anticholinergic to An Oral Beta Agonist Plus Theophylline in Asthma and BronchitisChest, 1982